BioNTech
status of covid vaccine program | BioNTech
Company
Deck Type
Sector
Industry
Deck date
August 2020
Slide
18 of 28
Related slides by other companies
Immix Biopharma
Investor Presentation
August 2023
direct path to line therapy in clinical trial plan cold | Immix Biopharma
Oculis
Investor Conference
June 2023
development status | Oculis
ATAI
Investor Presentation
March 2023
group average changes in beta power for low dose and high dose groups per time point average differences in each time point is compared to zero and time points with significant changes test were marked with asterisk preliminary data subject to change phase the effect was also time dependent showing a rapid onset of effect a delayed pharmacodynamic curve | ATAI
Fusion Pharmaceuticals
Investor Presentation
August 2023
future milestones by program | Fusion Pharmaceuticals
Other recent decks by BioNTech
See all presentations (12 decks)
Investor Presentation
August 2022
Results
August 2022
Investor Day
June 2022
Results
March 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights